Sensus Healthcare, Inc. (NASDAQ:SRTS) Shares Acquired by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP raised its holdings in Sensus Healthcare, Inc. (NASDAQ:SRTS - Free Report) by 128.0% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 166,590 shares of the company's stock after acquiring an additional 93,511 shares during the quarter. Dimensional Fund Advisors LP owned approximately 1.02% of Sensus Healthcare worth $888,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Chapin Davis Inc. purchased a new position in shares of Sensus Healthcare during the second quarter worth approximately $53,000. Sachetta LLC raised its position in Sensus Healthcare by 12.9% during the 2nd quarter. Sachetta LLC now owns 118,354 shares of the company's stock valued at $631,000 after purchasing an additional 13,544 shares in the last quarter. Hillsdale Investment Management Inc. purchased a new stake in shares of Sensus Healthcare in the 1st quarter worth $155,000. Creekmur Asset Management LLC purchased a new stake in shares of Sensus Healthcare in the 4th quarter worth $83,000. Finally, Acadian Asset Management LLC grew its position in shares of Sensus Healthcare by 578.6% during the 2nd quarter. Acadian Asset Management LLC now owns 45,124 shares of the company's stock worth $239,000 after buying an additional 38,474 shares in the last quarter. Institutional investors own 25.30% of the company's stock.

Sensus Healthcare Trading Down 1.1 %

Shares of SRTS traded down $0.07 during trading hours on Monday, hitting $6.55. The company had a trading volume of 80,494 shares, compared to its average volume of 291,095. The company has a market capitalization of $107.37 million, a PE ratio of 22.83 and a beta of 1.05. Sensus Healthcare, Inc. has a one year low of $1.79 and a one year high of $7.18. The company's fifty day moving average price is $6.20 and its two-hundred day moving average price is $5.39.

Sensus Healthcare (NASDAQ:SRTS - Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.03 by $0.07. The firm had revenue of $9.24 million for the quarter, compared to the consensus estimate of $7.00 million. Sensus Healthcare had a net margin of 18.27% and a return on equity of 13.46%. During the same quarter in the previous year, the firm earned ($0.02) EPS. Analysts forecast that Sensus Healthcare, Inc. will post 0.36 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on SRTS. HC Wainwright reaffirmed a "buy" rating and issued a $10.00 price objective on shares of Sensus Healthcare in a research note on Monday, August 12th. Roth Capital raised shares of Sensus Healthcare to a "strong-buy" rating in a research report on Friday, July 12th.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.